Preclinical studies has found that tibolone can display a weak estrogenic.
progestational and androgenic activity. The effect produced depends mainly
on the target tissue involved. Clinical data indicate that tibolone produce
s the hormonal effects needed to treat climacteric symptoms and to prevent
long-term effects of the menopause without stimulating breast and endometri
al tissues. This clinical profile would be produced by the tissue specific
activity of tibolone and its main metabolites. Tibolone's tissue specific a
ctivity may be explained by the interplay of several mechanisms, such as th
e metabolic conversion of tibolone to compounds with different biological a
ctivity. the classical interaction with the steroid receptor and the specif
ic local metabolism. within the target tissue. Therefore. the tissue respon
se and thus the clinical effect produced by tibolone in a given tissue seem
to depend on the predominating mechanisms and interactions present in that
tissue. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.